Stockreport

ObsEva and Yuyuan BioScience Technology Announce Sublicense Agreement to Develop and Commercialize Nolasiban in the People's Republic of China

ObsEva SA - Common Shares  (OBSV) 
Last obseva sa - common shares earnings: 3/5 01:00 am Check Earnings Report
PDF   Geneva, Switzerland, 13 January 2020 – ObsEva and Yuyuan BioScience Technology (“Yuyuan”) today announced that they have entered into a sublicense agreement to devel [Read more]